Clinical Trial Update: Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogenic adipose tissue-derived mesenchymal progenitor cells for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Allogenic adipose tissue-derived mesenchymal progenitor cells

Snippet

Sponsor: Shanghai AbelZeta Ltd. | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED